Nadler Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Nadler Financial Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,350	Closed	-$203K	–	130
2024 Q4	$203K	Sell	2,350 -375	-14%	-$33.9K	0.02%	125
2024 Q3	$259K	Hold	2,725	–	–	0.03%	100
2024 Q2	$249K	Sell	2,725 -270	-9%	-$24.1K	0.03%	96
2024 Q1	$272K	Hold	2,995	–	–	0.03%	89
2023 Q4	$244K	Sell	2,995 -1,340	-31%	-$105K	0.03%	95
2023 Q3	$346K	Hold	4,335	–	–	0.05%	72
2023 Q2	$341K	Sell	4,335 -40	-0.9%	-$3.13K	0.05%	74
2023 Q1	$340K	Sell	4,375 -30	-0.7%	-$2.31K	0.05%	78
2022 Q4	$342K	Buy	+4,405	New	+$325K	0.06%	76

Other funds holding PPH

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Nadler Financial Group's PPH Position: Q1 2025 in Review

Nadler Financial Group sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 2,350 shares — an estimated $203K sold.

Nadler Financial Group first reported a position in PPH in Q4 2022 and held it in 9 quarters. The position peaked at $346K in Q3 2023. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

Nadler Financial Group reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
Nadler Financial Group sold 2,350 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $203K.
Nadler Financial Group first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 9 quarters.
Nadler Financial Group's VanEck Pharmaceutical ETF position peaked at $346K in Q3 2023.
136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Nadler Financial Group's 13F filing for Q1 2025, filed 24 Apr 2025.